| Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
| actttcttttagGA |
| acttccttttagGA |
| 0.7 % |
![]() |
Data for this mutation
| Sample ID | MSH2 | MLH1 | MSH6 | MUTYH | APC |
|---|---|---|---|---|---|
| 37_L08.037_5253_--- | - | - | - | - | - |
| 7_-62845433E060753 | c.IVS1+9C>G (c.211+9C>G) c.IVS10+12G>A (c.1661+12G>A) | c.IVS11-8T>A (c.1039-8T>A) c.IVS13+14G>A (c.1558+14G>A) c.IVS14-19A>G (c.1668-19A>G) c.655A>G (p.Ile219Val) | - | - | - |
| 7_1005283E2K266 | c.148G>A (p.Ala50Thr) c.IVS10+12G>A (c.1661+12G>A) | c.IVS7+103G>C (c.588+103G>C) | - | - | - |
| Analysis | Result | Date | Origin | PMID/dbSNP |
|---|---|---|---|---|
| Clinical phenotype | Sporadic colorectal cancer < 50 years old (family 2) | 28/03/11 | 7 (Marseille) | |
| MMR function in tumor cells | MSI (mutation on BRAF, methylation of the MLH1 promoter) (patient A) | 29/09/08 | 37 (Lille) | |
| Clinical phenotype | Sporadic colorectal cancer 51 years old | 28/03/11 | 7 (Marseille) | |
| In vitro analysis | RT-PCR : normal splicing (patient A) | 14/08/08 | 37 (Lille) |
| Biological significance | Date | Comment |
|---|---|---|
| Neutral | 13/12/11 | --- |